2023 annual financial data
REGENXBIO 2023 Net margin
Direct answer
Net margin was -291.99%.
Operating income was -268,128,000 USD and net income was -263,494,000 USD.
Operating cash flow was -218,407,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 90,242,000 USD
- Operating income
- -268,128,000 USD
- Net income
- -263,494,000 USD
- Operating cash flow
- -218,407,000 USD